Abstract
The fatty acid oxygenases, cyclooxygenase and lipoxygenase, require hydroperoxides to achieve maximal rates of reaction, and their reaction products are hydroperoxides that can stimulate a faster oxygenation reaction. The cyclooxygenase can be stimulated to half-maximal velocity by 20 picomoles of lipid hydroperoxide per ml (1), while it can generate nanomoles of the hydroperoxide, prostaglandin G2 (PGG2). Soybean lipoxygenase, and all other lipoxygenases, also react faster as the level of lipid hydroperoxide is amplified. Thus, intracellular amplification of lipid hydroperoxides by the fatty acid oxygenases may be closely related to high rates of formation of eicosanoids (prostaglandins and leukotrienes). This relationship has broader importance when overproduction of eicosanoids is recognized to be a common occurrence in many major pathophysiological events (2). The intracellular amplification by the fatty acid oxygenases of “triggering” levels of hydroperoxide (3) to higher levels that permit pathological rates of eicosanoid synthesis needs careful study. Intracellular levels of to 10−9to 10−7 M lipid hydroperoxide seem likely to be involved in this amplification.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
R.J. Kulmacz and W.E.M. Lands, Requirements for hydroperoxide by the cyclooxygenase and peroxidase activities of prostaglandin H synthase. Prostaglandins 25, 531–540 (1983).
W.E.M. Lands, Interactions of lipid hydroperoxides with eicosanoid biosynthesis. J. Free Radicals Biol. Med. 1, 97–101 (1985).
W.E.M. Lands and P.J. Marshall, Peroxide stimulators of prostaglandin biosynthesis. IN: Rheumatology 85, (P.M. Brooks and J.R. York, Eds.), pp. 47–50, Elsevier, New York, 1985.
W.E.M. Lands and A.M. Hanel, Phenolic anticyclooxygenase agents in antiinflammatory and analgesic therapy. Prostaglandins 24, 271–277 (1982).
W.E.M. Lands, H.W. Cook and L.H. Rome, Prostaglandin biosynthesis: Consequences of oxygenase mechanism upon in vitro assays of drug effectiveness. Adv. Prost. Thromb. Res., 1, 7–17 (1976).
A.M. Hanel and W.E.M. Lands, Modification of anti-inflammatory drug effectiveness by ambient lipid peroxides. Biochem. Pharmacol. 31, 3307–3311 (1982).
P.J. Marshall and W.E.M. Lands, In vitro formation of activators for prostaglandin synthesis by neutrophills and macrophages from humans and guinea pigs. J. Lab. Clin. Med. 108. 525–534 (1986).
B. Chance, H. Sies and A. Boveris, Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59, 527–605 (1979).
P.J. Marshall, M.A. Warso and W.E.M. Lands, Selective microdetermination of lipid hydroperoxides. Anal. Biochem. 145, 192–199 (1985).
M.A. Warso and W.E.M. Lands, Presence of lipid hydroperoxide in human plasma. J. Clin. Invest. 75, 667–671 (1985).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Plenum Press, New York
About this chapter
Cite this chapter
Lands, W.E.M., Pendleton, R.B. (1987). Amplification of Tissue Peroxides in Disease. In: Cerutti, P.A., Nygaard, O.F., Simic, M.G. (eds) Anticarcinogenesis and Radiation Protection. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-6462-1_12
Download citation
DOI: https://doi.org/10.1007/978-1-4615-6462-1_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-6464-5
Online ISBN: 978-1-4615-6462-1
eBook Packages: Springer Book Archive